Century Therapeutics's top three insider shareholders as of March 23, 2026 are Venture Capital Vi, L.P. Versant (TenPercentOwner, 11.45Mn shares), Cellular Dynamics, Inc. Fujifilm (TenPercentOwner, 6.96Mn shares), Brent Pfeiffenberger (President And Ceo, 3.77Mn shares).
| Holder | Position | Shares (Direct) | Shares (Indirect) | Report Date |
|---|---|---|---|---|
| Venture Capital Vi, L.P. Versant | 11,452,014 | 0 | 11 Aug, 2022 | |
| Cellular Dynamics, Inc. Fujifilm | 6,955,207 | 0 | 23 Jun, 2021 | |
| Brent Pfeiffenberger | President And Ceo | 3,710,958 | 0 | 13 Mar, 2026 |
| Chad Cowan | Chief Scientific Officer | 1,177,045 | 0 | 13 Mar, 2026 |
| Venture Capital Vi, L.P. Versant | 0 | 714,095 | 23 Jun, 2021 | |
| Gregory Russotti | See Remarks | 515,427 | 0 | 16 Mar, 2026 |
| Douglas Carr | Svp Finance Operations | 507,261 | 0 | 16 Mar, 2026 |
| Michael Craig Diem | Chief Financial Officer | 253,533 | 0 | 03 Nov, 2023 |
| Adrienne Farid | Chief Operations Officer | 250,141 | 0 | 11 Jun, 2025 |
| Morgan Conn | Chief Finanical Officer | 79,648 | 0 | 12 Mar, 2025 |
| Hyam Levitsky | President Of Rd | 24,000 | 0 | 11 Mar, 2024 |
| Daphne Quimi | 5,000 | 0 | 16 Sep, 2024 |
* Please note that the shares above only reflect shares from the fund portfolio and the institutional portfolio. Shares from the personal portfolio are excluded from this Institutional Ownership Page. See these insiders' latest transactions here on Insider Page.
| Transaction Date | Insider Name | Security Class | Transaction Type | Shares Traded | Price | Shares Remaining | Ownership | Code |
|---|---|---|---|---|---|---|---|---|
| 12 Mar, 2026 | Douglas Carr | Common Stock | D | 7,043 | $2.55 | 507,261 | D | S |
| 12 Mar, 2026 | Gregory Russotti | Common Stock | D | 10,076 | $2.55 | 515,427 | D | S |
| 11 Mar, 2026 | Chad Cowan | Common Stock | D | 1,431 | $2.73 | 1,177,045 | D | F |
| 11 Mar, 2026 | Brent Pfeiffenberger | Common Stock | D | 55,397 | $2.73 | 3,710,958 | D | F |
| 09 Mar, 2026 | Douglas Carr | Common Stock | D | 247 | $2.54 | 514,304 | D | S |
| 09 Mar, 2026 | Gregory Russotti | Common Stock | D | 479 | $2.54 | 525,503 | D | S |
| 06 Mar, 2026 | Brent Pfeiffenberger | Common Stock | D | 463 | $2.56 | 3,766,355 | D | F |
| 13 Feb, 2026 | Brent Pfeiffenberger | Common Stock | D | 31,172 | $1.75 | 3,766,818 | D | F |
| 03 Feb, 2026 | Douglas Carr | Common Stock | D | 323 | $1.82 | 514,551 | D | S |
| 02 Feb, 2026 | Brent Pfeiffenberger | Common Stock | A | 475,000 | $0.00 | 3,797,990 | D | A |
| 02 Feb, 2026 | Douglas Carr | Common Stock | A | 110,000 | $0.00 | 514,874 | D | A |
| 02 Feb, 2026 | Chad Cowan | Common Stock | A | 135,000 | $0.00 | 1,178,476 | D | A |
| 02 Feb, 2026 | Gregory Russotti | Common Stock | A | 135,000 | $0.00 | 525,982 | D | A |
| 02 Feb, 2026 | Douglas Carr | Stock Option (right to buy) | A | 225,000 | $0.00 | 225,000 | D | A |
| 02 Feb, 2026 | Brent Pfeiffenberger | Stock Option (right to buy) | A | 945,000 | $0.00 | 945,000 | D | A |
| 02 Feb, 2026 | Chad Cowan | Stock Option (right to buy) | A | 265,000 | $0.00 | 265,000 | D | A |
| 02 Feb, 2026 | Gregory Russotti | Stock Option (right to buy) | A | 265,000 | $0.00 | 265,000 | D | A |
| 02 Jan, 2026 | Chad Cowan | Common Stock | D | 1,611 | $1.00 | 1,043,476 | D | F |
| 22 Dec, 2025 | Chad Cowan | Common Stock | A | 58,060 | $0.85 | 1,045,087 | D | P |
| 12 Dec, 2025 | Brent Pfeiffenberger | Common Stock | A | 52,000 | $0.58 | 3,322,990 | D | P |